The expression of NEK2, NEK6, and NEK11 were related to colorectal cancer [30, 38–40], NEK2, NEK3, NEK5, NEK6, and NEK8 to breast cancer [11, 41–45], and NEK2 and NEK6 to prostate cancer [16, 46]. Here, NEK11 is linked to prostate carcinoma.